Mostrando 10 resultados de: 57
Publisher
American Journal of Therapeutics(20)
Revista Latinoamericana de Hipertension(14)
Current Pharmaceutical Design(5)
Vessel Plus(4)
Archivos Venezolanos de Farmacologia y Terapeutica(3)
Área temáticas
Enfermedades(43)
Fisiología humana(28)
Farmacología y terapéutica(20)
Salud y seguridad personal(14)
Medicina y salud(9)
Área de conocimiento
Medicina interna(17)
Enfermedad cardiovascular(15)
Fisiología(9)
Diabetes(7)
Obesidad(7)
AMPK as target for intervention in childhood and adolescent obesity
ReviewAbstract: Childhood obesity is a major worldwide health problem. Intervention programs to ameliorate the ratePalabras claves:Autores:Aguirre M.A., Arráiz N., Manuel Velasco, Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusThe maracaibo city metabolic syndrome prevalence study: Design and scope
ArticleAbstract: The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atheroPalabras claves:Blood pressure, Cardiovascular Risk Factors, cross-sectional studies, dyslipidemia, Metabolic syndromeAutores:Amell A., Arráiz N., Cabrera M., Cano J.R., Cano R.A., Cano-Ponce C., Finol F., González J., Lopez-Miranda J., Luti Y., Manuel Velasco, Marcano R.P., Mengual-Moreno E., Miranda J.L., Montes J., Reyna-Villasmil N., Rojas E.R., Sánchez D., Sanchez W., Valmore Bermúdez, Vega L., Velasco M.Fuentes:scopusThe quest for immunotherapy in atherosclerosis: CANTOS study, interleukin-1β and vascular inflammation
OtherAbstract:Palabras claves:Autores:Manuel Velasco, Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusThe role of adiponectin in endothelial dysfunction and hypertension
ArticleAbstract: It has been two decades since the discovery of adiponectin, and today its role in insulin resistancePalabras claves:adiponectin, Endothelial dysfuction, Hypertension, Nitric oxide, obesity, renin-angiotensin-aldosterone systemAutores:Bolli P., Daloha Rodríguez-Molina, Faria J., Fidilio E., Israili Z.H., Manuel Velasco, Rodríguez-Molina D., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusTrimetazidine diminishes fasting glucose in rats with fasting hyperglycemia: a preliminary study.
ArticleAbstract: Trimetazidine is a drug with cardioprotective properties used in coronary artery disease. Its effectPalabras claves:Autores:Ambard M.J., Bermúdez F.A., Cano-Ponce C., Contreras F., Escalona D., Manuel Velasco, Medina M.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusStress and antioxidant vitamins in type 2 diabetic patients
ArticleAbstract: Hyperglicemia increases free radicals generation, surpassing the antioxidant defense capacity. ObjecPalabras claves:Antioxidant vitamins, diabetes mellitus, Oxidative StressAutores:Contreras F., Joselyn Zula, Lares M., Manuel Velasco, Martín V., Maurera E., Rajas J., Rodriguez D., Rodriguez R., Rubén Rodriguez, Sánchez M., Sepulveda L., Sutil R., Valmore Bermúdez, Velasco M.Fuentes:googlescopusTargeting hypertension in patients with cardiorenal metabolic syndrome
ReviewAbstract: Diabetes mellitus coexisting with hypertension is greater than chance alone would predict. HypertensPalabras claves:Antihypertensive therapy, Blood pressure, Cardiorenal metabolic syndrome, DIABÉTES, Hypertension, Kidney disease, Pharmacologic therapy, RAAS, Reninangiotensin- aldosterone systemAutores:Bolli P., Israili Z.H., Manuel Velasco, Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusAssociation between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in maracaibo, Zulia State, Venezuela
ArticleAbstract: Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardPalabras claves:ApoE, Cardiovascular disease, hypercholesterolemia, Lipids profile, polymorphismsAutores:Arráiz N., Carem Prieto, Escalona C., Manuel Velasco, Reyes F., Rondón N., Sánchez M.P., Sanz E., Valmore Bermúdez, Velasco M.Fuentes:scopusBiochemical and clinical characterization of metabolic phenotypes: A cross-sectional study from Maracaibo city, Venezuela
ArticleAbstract: Background: In 1980, Reuben Andresen observed that in certain individuals, obesity did not increasePalabras claves:Coronary risk, Metabolic phenotypes, Metabolically healthyobese, Metabolically unhealthy lean, Two-step clusterAutores:Añez-Ramos R., Calvo M.J., Cerda M., Garicano C.M.D., Graterol M., Graterol R., Hernández J.D., Manuel Velasco, Martínez M.S., Mindiola A., Olivar L.C., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M., Wilches-Duran S.Fuentes:scopusBiologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Manuel Velasco, Martínez M.S., Mengual-Moreno E., Paola Valero, Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopus